by Extivita | Aug 22, 2012 | Cancer
Abstract: Temozolomide (TMZ) is an oral alkylating agent widely used in the treatment of refractory glioma. Its efficacy is limited, however, by poor cancer cell penetration and drug resistance. The present study, therefore, aimed to investigate whether hyperbaric...
by Extivita | Jan 11, 2012 | Cancer
Abstract: Temozolomide (TMZ) has anti-tumor activity in patients with malignant glioma. Hyperbaric oxygen (HBO) may enhance the efficacy of certain therapies that are limited because of the hypoxic tumor microenvironment. We examined the combined effects of TMZ-HBO in...
by Extivita | May 26, 2009 | Cancer
Abstract: The efficacy of intravenous administration of 400 mg carboplatin/m(2) body surface area over 60 minutes combined with hyperbaric oxygenation (HBO) therapy (0.2 MPa for 60 min) was investigated in 6 Japanese patients (aged 36-67 years) with malignant or...
by Extivita | Feb 5, 2008 | Cancer
Abstract: Effective treatment options are limited for patients with recurrent glioblastoma multiforme (GBM), and survival is usually or=70, 125I seed activity>or=0.8 mCi/cm3 of tumor cavity, and age
by Extivita | Jul 13, 2004 | Lymphoma
Abstract: Bratsas, Stephanides, Spyropoulos, Zachariades, Androulakakis, , , , (2004). Hyperbaric oxygen therapy for cyclophosphamide induced refractory hemorrhagic cystitis in a child. The Journal of urology, 2004...
